Valeant Pharmaceuticals Enters into Third Amended and Restated Credit and Guaranty Agreement

Valeant Pharmaceuticals International, Inc. and certain of its subsidiaries entered into a third amended and restated credit and guaranty agreement, providing Valeant Pharmaceuticals International, Inc. with revolving facilities and term facilities in the aggregate principal amount of $3.1 billion. The transaction was entered into by Valeant Pharmaceuticals International, Inc., as the borrower, certain subsidiaries of Valeant Pharmaceuticals International, Inc., including V-BAC Holding Corp, Valeant Canada GP Limited and Valeant Canada S.E.C./Valeant Canada LP, as guarantors, Goldman Sachs Lender Partners LLC as administrative agent and collateral agent and a syndicate of lenders.

Valeant Pharmaceuticals International, Inc. is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics in the United States, Canada, Latin America, Eastern and Central Europe, Australia, South East Asia and South Africa.

Valeant Pharmaceuticals International, Inc. and its subsidiaries were represented in Ontario, Québec and Alberta by Norton Rose Canada LLP with a team comprising Peter Wiazowski, Suzana Lobo, Aimee Halfyard, Aditya Rebbapragada, Sandro Muzzo and Taylor Wood; in British Columbia by Warren Brazier of Clark Wilson LLP; in Manitoba by Lindsay Martens of Fillmore Riley LLP; in Nova Scotia by Deanne MacLeod; in New Brunswick by Alanna Waberski of Stewart McKelvey; in the United States by Skadden, Arps, Slate, Meagher & Flom LLP with a team comprising Robert Copen, Alexandra Margolis and Nick Kodes; in Barbados by Chancery Chambers with a team comprising Tammy Thornhill and Angela Robinson; in Luxembourg by Baker & McKenzie Luxembourg with a team comprising Bertrand Job, Laurent Fessmann and Nicolas Ronzel; in Switzerland by Baker & McKenzie Zurich with a team comprising Matthias Courvoisier and Theodor Haertsch; in Lithuania by Tarke Grunte Sutkiene with a team comprising Marius Matonis, Deimante Korsakaite and Ieva Dosinaite; and in Australia by Baker & McKenzie with a team comprising Howard Fraser, Michael Dearden and Amy Middlebrook.

Goldman Sachs Lending Partners LLC and the syndicate of lenders were represented in Ontario and Québec by Osler, Hoskin & Harcourt LLP with a team consisting of Michael Hart, Benjamin Leith, Constantine Troulis and Maxime Laverdière; and in the United States by Cahill, Gordon & Reindel LLP with a team consisting of Noah Newitz, Josiah Slotnick, Dylan Brown and Samir Ahuja.


Warren G. Brazier Benjamin Leith Noah Newitz Aimee L. Halfyard Maxime Laverdière Alanna D. Waberski Suzana A. Lobo Aditya Rebbapragada Peter J. Wiazowski Michael S. Hart Lindsay Martens Deanne MacLeod Constantine Troulis


Norton Rose Fulbright Canada LLP Clark Wilson LLP Fillmore Riley LLP Skadden, Arps, Slate, Meagher & Flom LLP Stewart McKelvey